Healthy Living/WellnessLilly's Type 2 diabetes drug trials halted by the FDA The FDA has denied an application for approval of Type 2 diabetes drug empagliflozin, citing quality control standards at the manufacturing plant. The drug is been produced by Eli Lilly and Co and Boehringer Ingelheim.by Tabitha Laffernis
Healthy Living/WellnessBaby born with HIV likely cured of the virus, thanks to early treatmentby Tabitha Laffernis
TechNo Glass allowed - San Francisco bar bans Google Glass, but what if they're prescription?by Malarie Gokey
Healthy Living/WellnessThe not-so-sweet truth: Sugar intake 'should be halved,' says WHOby Tabitha Laffernis
Hell hath no fury as Rachel Canning: NJ teen sues parents for money but judge says 'no'by Maryanne Moll
TechCyber attacks escalate between Ukraine and Russia, as both sides struggle to control the mediaby Malarie Gokey
TechRoku Streaming Stick takes on Google ChromeCast and has 1,200 channels and apps availableby James Geddes
Healthy Living/WellnessCDC's Vital Signs report finds antibiotics are inconsistently prescribedby Tabitha Laffernis
TechFreedomPop 'Snowden Phone': Has security become the selling point of smartphones of the future?by Randell Suba
Healthy Living/WellnessBoys suffer more than girls after moving out of poor neighborhoodsby Pierre Dumont
Waymo Robotaxis Hit London Streets as Driverless Cars Prepare to Challenge Uber, Transform Urban Travel